CEPHALOSPORIN DERIVATIVES AND RELATED COMPOUNDS

Copyright, Purdue Research Foundation, 1996


| Chemotherapy Table of Contents | | Address |

Because the research leading to the development of the newer derivatives grew out of modifications of the basic cephem nucleus, other groups of drugs, e.g., the cephamycins and oxacephems, tend to be lumped with the cephems (cephalosporins).

Classes of Cephalosporins and Related Drugs

Cephems, Oxacephems, and cephamycins

MEMBERS OF GROUP

CLASSIFICATION -- STRUCTURAL & SPECTRUM

Cephems are the "true" cephalosporins, but the others are closely related. Cephamycins differ from cephems by having a methoxy group at position R3 of the 7-aminocephalosporanic acid structure shown below.

Source: Cephalosporium acremonium

All contain beta-lactam ring which is required for activity

Modification of properties due to





7-Aminocephalosporic acid


Three Generations of Cephalosporins

By modifying the side chain (position 7) and the substituents on position 3 of the ring.

Major differences in the three generations is increasing activity against a variety of gram negative species, decreasing susceptibility to beta-lactamases.

According to AMADE5th, the first and second generation analogues are "...not...regarded as antibiotics of first choice for treatment of most infections because of the availability of equally effective and less expensive alternatives." ... "The cephalosporins may be used as primary drugs in non-hospital acquired Klebsiella infections depending on organism susceptibility."

Dose intervals listed below are the LONGEST listed in any reference material and not necessarily that which might be recommended in a particular therapeutic application.

FIRST generation:

Members:
ALL ROUTES

cephradine [ANSPOR], (PO,IV/IM), q6h, t-half 0.8 h

ORAL

cephalexin [KEFLEX] oral, q6h, t-half 0.9 h

cefadroxil [DURICEF], oral, q12h, t-half 1.5 h

PARENTERAL

cephalothin [KEFLIN] (IV/IM), q4h, t-half 0.6h

cephapirin [CEFADYL], (IV/IM), q4h, 1.2 h

cefazolin [ANSEF], (IV/IM), q6h, t-half 1.8 h

Spectrum

Similar to "broad spectrum" (extended spectrum) penicillins, e.g., amoxicillin, except that they have greater beta-lactamase resistance.

Tend to be ineffective against "methicillin-resistant" Staphylococci. Low affinity for the "transpeptidase?"

Not as good as penicillins for Bacteroides spp, enterococci, and most indole-positive proteus.

Not good for CNS infections -- broken down too rapidly by deacetylase. (3-position)

High and consistently effective against Staphylococcus aureus and Streptococcus pneumoniae

Moderate activity against coli, Proteus mirabilis, and Klebsiella.

SECOND generation:

Members:
ORAL

cefaclor [CECLOR], PO, q8h, t-half 0.6-0.8 h

PARENTERAL

cefamandole [MANDOL], (IV/IM), q4h, t-half 0.6-1 h

cefuroxime [ZINACEF,KEFUROX], (IV/IM), q8h, t-half 1.3-1.7 h

ceforanide [PRECEF], (IV/IM), q12h, t-half 2.7-3 h

cefonicid [MONOCID], (IV/IM), q24h, t-half 3.5-4.5 h

cefoxitin (cefamycin) [MEFOXIN], (IV/IM), q6h, t-half 0.7-1 h

cefotetan (cefamycin) [CEFOTAN], (IV/IM), q12h, t-half 3-4.6 h

Spectrum

Not good for meningitis because of poor and unpredictable concentrations in CSF. AMADE5th & USPDI.

In addition to gram negative organisms of first generation, have effectivness against E. coli, Proteus mirabilis, Klebsiella, and indole-positive Proteus. Cefamandole also adds moderate activity against Enterobacter.

Cefamycins have increased resistance to beta-lactamases of gram negative organisms relative other 2nd generation cephems. Cefoxitin similar to cefamandole except some activity against Bacteroides fragilis, and not useful for Enterobacter.

THIRD generation:

Members:
ORAL

cefixime [SUPRAX], (PO), q12h, t-half 3-4 h

PARENTERAL

cefotaxime [CLAFORAN], (IV/IM), q4h, t-half 1.1 h

ceftizoxime [CEFIZOX], (IV/IM), q8h, t-half 1.4-1.8 h

cefoperazone [CEFOBID], (IV/IM), q12h, t-half 1.9-2.1 h

ceftazidime [FORTAZ], (IV/IM), q12h, t-half 1.8 h

ceftriaxone [ROCEPHIN], (IV/IM), q24h, t-half 6-9 h

Moxalactam (Oxacephem) [MOXAM, LAMOXACTAM, LATAMOXEF], (IV/IM) q8h, t-half 2.0-2.3 h

Spectrum

Most active cephalosporins against E. coli, Proteus mirabilis, Klebsiella, indole-positive Proteus, and Enterobacter

Increased activity (relative to earlier generations) against Pseudomonas aeruginosa

INEFFECTIVE against Enterococcus

Veterinary

ceftiofur [NAXCEL], q12h. Approved for injection. Pasteurella and Haemophilus somnus in cattle; Salmonella spp. in hogs.

cephapirin -- mastitis preparations

cephalexin -- oral

cephalothin -- injection

Mechanism of Action

Characteristic of beta-lactams

Pharmacokinetics

Absorption

Highly variable -- Many limited to parenteral adminstration because of poor bioavailability. A few are for PO administration.

Some acid stable cephalosporins are still poorly bioavailable via PO administration

Cefixime (3, po) -- F = 40-50%

Cefuroxime axetil (2, po) -- F = 36-52%; NB despite poor bioavailability, is intended for PO admin. Cefuroxime [2] is for parenteral use.

Food and/or milk


Tissue                Drug              Concentration                       

--------------------- ----------------- -------------------                 
----------            -------                                               

Bile &/or             All               Therapeutic                         
gallbladder                                                                 

Bone & joints         All parenteral    Therapeutic                         

Cardiovascular        All               Therapeutic                         

CSF                   cefotaxime [3]    Therapeutic                         

                      ceftazidime [3]   Therapeutic                         

                      ceftriaxone [3]   High                                

                      cefuroxime [2]    Therapeutic                         

                      moxalactam [3]    Variable                            

                      Others            Low / unpredictable                 

NB: some variation                                                          
with ADMADE90                                                               
information printed                                                         
below                                                                       

Eye                   ceftazidime [3]   Therapeutic                         

                      ceftizoxime [3]   Therapeutic                         

                      cefuroxime [2]    Therapeutic                         

                      Others            Low                                 

Intra-abdominal       Most              Therapeutic                         

Kidneys               All               High; Therapeutic                   

Middle ear            cefaclor [2]      Therapeutic                         

                      cefoperazone [3]  Therapeutic                         

                      cefotaxime [3]    Therapeutic                         

                      cephalexin [1]    (Large therapeutic doses)           

                      cephradine [1]    Therapeutic                         

Placenta              All               Cross readily                       

Respiratory tract     Most              Therapeutic                         

Skin & soft tissue    Most              Therapeutic                         

Urinary tract         All               High; Therapeutic                   

Data from UPDI8th,                                                          
1988. p632                                                                  



Distribution

Considered useful for CNS infections: cefuroxime [2]; Most third generation (cefoperazone [3] variable).

Biliary concentrations adequate with third generation cephalosporins, especially Cefoperazone [3].

Urinary concentrations of most are excellent

Biotransformation

Not a prominent feature of the group

Deacetylated: cephalothin (1), cephapirin (1) and cefotaxime (3), Less active metabolites eliminated via kidney

Elimination

Probenecid sensitivity: [AMADE90,2:19-21]

Probenecid sensitive -- All first and second generation except ceforanide. Third generation -- cefotaxime, ceftizoxime. (Cefixime unknown)

Probenecid insensitive -- ceforanide, \sAll third generation except cefotaxime, ceftizoxime, and perhaps cefixime.

Decreased renal function requires decreased dosage of following oral cephalosporins: cephalexin (1), cephradine (1), cefadroxil (1), cefuroxime axetil (2), and cefixime. Not cefaclor (2).

Decrease renal function requires decreased dosage of all parenteral first and second generation cephalosporins.

Eliminated primarily by glomerular filtration: ceftazidime (3) and moxalactam (3).

Ceftriaxone (3) -- eliminated via glomerular filtration (60%) and biliary secretion (40%). Has longest half life of any third generation cephalosporin. Half-life = 6-9h; Dosage: Once per day if non CNS infection.

Adverse Effects

Hypersensitivity --

most common adverse effect and very similar to penicillins

Majority of reactions -- maculopapular rashes that appear after a few days of Rx. Frequently accompanied by fever and eosinophilia. Other, more severe types of reactions are uncommon or rare.

As many as 20% of patients demonstrate cross-reactivity between penicillins and cephalosporins in immunologic studies, but clinical reports indicate a lower frequency (5-10%).

AMADE90-2:15 says cross-hypersensitivity with penicillins is low. Less than 5% of patients with history of penicillin allergy are also allergic to cephalosporins.

RENAL toxicity:

Generally regarded as not nephrotoxic at recommended doses.

May temporarily increase BUN.

Cephalothin has caused acute tubular necrosis, but may be most important if pre-existing renal disease

Should be particularly cautious when mixing with aminoglycosides.

DISULFIRAM-like reaction

Alcohol intolerance -- characteristic of those that have methylthiotetrazole side chain. Cephalosporins with which one should avoid alcohol during and up to 3 days after a course of therapy include (n = generation): cefamandole (2, inj), cefoperazone (3, inj), moxalactam (3, inj), and cefotetan (2).

Disulfiram is an inhibitor of acetaldehyde dehydrogenase, the second step in metabolizing ethyl alcohol. This results in build-up of acetaldehyde which is very toxic.

HEMATOLOGIC reactions including Bleeding related to hypoprothrombinemia, thrombocytopenia, and/or platelet dysfunction.

Most often associated with MOXALACTAM in patients who are old, poorly nourished, or have poor renal function.

Also seen with cefamandole (2), cefoperazone (3), and cefotetan (2).

IRRITANTS

Cephalosporins are irritants and can cause PAIN at IM sites and THROMBOPHLEBITIS at IV sites.

First Generation: Least irritant is cefazolin

NOT RECOMMENDED for intrathecal injection

Interference with Laboratory Tests

False positive for urine glucose with some types of tests.

High concentrations of cefoxitin (2), ceforanide (2), or cephalothin (1) may produce false results in creatinine measurements.

References

[GG7th] Chapter 50, by Mandell, G.L., and M· Sande in Goodman & Gilman's The Pharmacological Basis of Therapeutics, eds., A.G. Gilman, L.S. Goodman, T.W. Rall, F. Murad. Macmillan, NY, 1985.

[GG8th] Chapter 46, by Mandell, G.L., and M· Sande in Goodman & Gilman's The Pharmacological Basis of Therapeutics, eds., A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor. Pergamon Press, NY, 1990.

[USP/DIxx] where xx = year of current edition. Drug Information for the Health Care Professional, United States Pharmacopoeil Convention. FANTASTIC! Updated annually.

[AMADExx-nn:nn] AMA Drug Evaluations Subscription. xx = year for particular monograph and nn:nn = section and page. Individual monographs updated at irregular intervals. Published by the American Medical Association, Chicago. Has introductory sections for groups of drugs followed by monographs for each drug preparation. Excellent!

Kagan, Ch. 3.

Antimicrobial Therapy in Veterinary Medicine. Prescott, J.F. and Baggot, J.Desmond, Blackwell Scientific Publications, Boston, MA, pp. 367. 1988.

Smith and Reynard ...

Study Questions

  1. How do the cephalosporins compare to penicillin G with respect to mechanisms of action, routes of elimination, psectrum of activity, etc., are concerned? Note that first and second generation cephalosporins may more closely resemble ampicillin's spectrum of activity.
  2. What is the difference betwen the various generations of the cephalosporins?
  3. Why is it so difficult to achieve therapeutic concentrations of first generation cephalosporins in the CSF?
  4. Is there any reason to be concerned about hypersensitivity to cephalosporins if a patient is highly allergic to penicillins? What about cross reactivity betwen the penicillins?
  5. How do some of the third generation cephalosporins compare to penicillin G in their affinity for the penicillin binding proteins of such organisms as streptococci? Does this make them better or worse candidates for use in therapy of these and other organisms sensitive to penicillin G?
  6. Which of the cephalosporins are associated with disulfiram-like adverse effects?
  7. Which of the cephalosporins have been associated with producing a bleeding tendency?
  8. What 4 cephalosporins are widely used and/or specifically indicated for use in veterinary medicine?

| Return to chemotherapy title page | | top |
Gordon L. Coppoc, DVM, PhD
Professor of Veterinary Pharmacology
Head, Department of Basic Medical Sciences
School of Veterinary Medicine
Purdue University
West Lafayette, IN 47907-1246
Tel: 317-494-8633Fax: 317-494-0781
Email: coppoc@vet.purdue.edu

Last modified 8:58 PM on 2/20/96 GLC